CXCR4 and breast carcinoma: In addition, the CXCR4 promoter displayed a significantly lower mean relative luciferase activity in the human liver tissue slices (0.18%) than in the primary breast cancer samples (37.7%) or breast cancer tissue slices (36.0%).